Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,501 | -6,466 | -5,026 | -4,773 | -2,019 |
| Depreciation Amortization | 3,193 | 3,101 | 3,932 | 4,325 | 3,724 |
| Income taxes - deferred | N/A | N/A | N/A | -9 | -39 |
| Accounts receivable | -181 | 142 | 199 | -266 | -841 |
| Other Working Capital | 137 | -610 | -301 | 18 | -268 |
| Other Operating Activity | 855 | 870 | 414 | 6,417 | 2,636 |
| Operating Cash Flow | $2,503 | $-2,963 | $-782 | $5,712 | $3,193 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,076 | -2,983 | -863 | -2,199 | -4,476 |
| Purchase Sale Intangibles | -94 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -94 | 58 | 2,626 | -40 | 255 |
| Investing Cash Flow | $-3,170 | $-2,925 | $1,763 | $-2,239 | $-4,221 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 700 |
| Debt Repayment | -155 | -12 | -363 | -433 | -990 |
| Common Stock Issued | 778 | N/A | 694 | 534 | 566 |
| Common Stock Repurchased | N/A | -12 | -444 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -94 | -700 | 0 |
| Financing Cash Flow | $623 | $-24 | $-207 | $-599 | $276 |
| Exchange Rate Effect | 319 | -999 | 725 | -82 | 24 |
| Beginning Cash Position | 3,362 | 10,273 | 8,774 | 5,982 | 6,710 |
| End Cash Position | 3,637 | 3,362 | 10,273 | 8,774 | 5,982 |
| Net Cash Flow | $275 | $-6,911 | $1,499 | $2,792 | $-728 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,503 | -2,963 | -782 | 5,712 | 3,193 |
| Capital Expenditure | -3,076 | -2,995 | -1,341 | -2,199 | -4,476 |
| Free Cash Flow | -573 | -5,958 | -2,123 | 3,513 | -1,283 |